PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1836310
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1836310
Ingestible sensors market size was valued at US$ 1,245.45 Million in 2024, expanding at a CAGR of 10.8% from 2025 to 2032.
Ingestible sensors are tiny, swallowable electronic devices designed to monitor and transmit health-related data from inside the body. Once ingested, they collect information such as pH levels, temperature, pressure, or medication adherence and send it wirelessly to external receivers. These sensors help healthcare providers track internal body conditions in real time, enabling accurate diagnosis, personalized treatment, and improved patient compliance without invasive procedures, ultimately advancing modern healthcare monitoring and management systems.
Ingestible Sensors Market- Market Dynamics
Increasing incidence of gastrointestinal disorders to propel market demand
Rising prevalence of gastrointestinal disorders is fueling demand for innovative diagnostic tools, with the World Health Organization (WHO) reporting that digestive diseases affect nearly 20% of the global population annually. Besides, growing elderly population increases the need for non-invasive monitoring. However, High device costs and concerns over data privacy & security to restrain the market growth in the coming years. On the contrary, rxpanding telehealth services create new applications for ingestible sensors. Moreover, government initiatives to promote digital health will boost market potential during the forecast period.
Ingestible Sensors Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.8% over the forecast period (2025-2032)
Based on Component segmentation, wearable patch/data recorder was predicted to show maximum market share in the year 2024
Based on Sensor Type segmentation, image sensor was the leading Sensor Type in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Ingestible Sensors Market is segmented on the basis of Component, Sensor Type, Vertical, and Region.
The market is divided into three categories based on Component: software, wearable patch/data recorder, and sensor. The wearable patch/data recorder segment is expected to hold the major market share during the forecast period, as it plays a crucial role in collecting, transmitting, and analyzing real-time physiological data for accurate diagnostics and monitoring.
The market is divided into three categories based on Vertical: medical, sports & fitness, and others. Among these, the medical segment is expected to account for the major market share during the forecast period, driven by rising applications in disease diagnostics, drug delivery monitoring, and patient health management.
Ingestible Sensors Market- Geographical Insights
The North America region is expected to hold the major market share during the forecast period, supported by advanced healthcare infrastructure, high adoption of digital health technologies, and favorable regulatory frameworks.
Meanwhile, the Asia-Pacific region is projected to grow at the fastest rate, driven by expanding healthcare access, rising prevalence of chronic diseases, and increasing investments in digital health innovations across countries like China, India, and Japan.
Rising demand for non-invasive health monitoring is driving companies to focus on innovation and advanced product development. Market participants are investing heavily in miniaturization technologies, wireless communication improvements, and integration with digital health platforms to enhance usability. Strategic collaborations with healthcare providers and research institutions are helping expand clinical applications and improve adoption rates. Additionally, firms are emphasizing regulatory approvals, product reliability, and cost optimization to strengthen market presence while catering to the growing need for personalized healthcare solutions.
In July 2025, UCLA and The Lundquist Institute initiated a NIH-funded clinical study with 110 participants to evaluate the ID-Cap(R) ingestible sensor system, aiming to enhance HIV treatment adherence through real-time monitoring and integrated digital interventions.